Brian Rood, MD
Basic profileDirector, Clinical Neuro-Oncology; Medical Director, Brain Tumor Institute · Children's National
Brian Rood is Director, Clinical Neuro-Oncology; Medical Director, Brain Tumor Institute at Children's National. OpenAlex indexes 164 publications with 4,293 citations (h-index 30); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Updated 25 Oct 2026
Brian Rood, MD, is Director, Clinical Neuro-Oncology at Children's National Hospital. The public record shows 143 publications with 3,735 citations (h-index 30), centered on Glioma Diagnosis and Treatment, Neuroblastoma Research and Treatments, Cancer Genomics and Diagnostics. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 2 companies, 1 NIH-funded awards (2007–2011).
- Most recent indexed publication: 2026 · The Journal of experimental medicine
- Top research focus: Glioma Diagnosis and Treatment
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 25 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 50.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
111 Michigan Ave NW
Washington, DC 20010-2978
Telephone
202-884-2800Provider last certified this registry record 2 Sept 2021 · collected 28 Jul 2026.
Clinical trials
Updated 25 Oct 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Sponsor: Children's National Research Institute
- Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors
Sponsor: Pediatric Brain Tumor Consortium
Industry payments
Updated 25 Oct 2026
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Day One BiopharmaceuticalsProgram year20251 payment
- Illumina, Inc.Program year20231 payment
NIH funding
Updated 25 Oct 2026
1 NIH research award on record, funded 2007–2011 per NIH RePORTER. The latest:
- Creation of a PDGF-C Autocrine Loop by HIC1 Inactivation
Children'S National Medical Center
FY2011$145,800K08NS051477 - Creation of a PDGF-C Autocrine Loop by HIC1 Inactivation
Children'S National Medical Center
FY2010$145,800K08NS051477 - Creation of a PDGF-C Autocrine Loop by HIC1 Inactivation
Children'S National Medical Center
FY2009$145,800K08NS051477
Congress activity
Updated 25 Oct 2026
6 congress contributions (2014–2024) across AACR, ASTRO per OpenAlex. The most recent:
- Abstract 3955: A proteogenomic study of high-grade glioma among adolescents and young adults
AACR Annual Meeting
AACR2024Co-author - Abstract 4889: Integrative multi-omic analysis reveals novel prognostic biological entities in pediatric medulloblastoma
AACR Annual Meeting
AACR2024Co-author - Abstract 1067: Proteogenomic discovery of novel tumor proteins as neoantigens for personalized T cell immunotherapy in pediatric medulloblastoma
AACR (meeting unresolved)
AACR2020Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 25 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- CAMKV kinase drives neuroblastoma growth and acts as a novel therapeutic target.
The Journal of experimental medicine
Article2026 - Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.
Nature medicine
Clinical Trial2026 - Multi-Institutional Annotated Multiparametric MRI Dataset of Pediatric High-Grade Gliomas.
Radiology. Artificial intelligence
Article2026
Most-cited works
by citation count (OpenAlex)- 01Proteogenomic and metabolomic characterization of human glioblastomaArticle658 citations2021
- 02
- 03Medulloblastoma: Present Concepts of Stratification into Risk GroupsArticle161 citations2003
- 04
- 05Spatial heterogeneity in medulloblastomaArticle142 citations2017
Network
Updated 25 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 25 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/brian-rood-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 25 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →research.childrensnational.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →appointments.childrensnational.org ↗
- BA
English Literature, Pennsylvania State University
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →research.childrensnational.org ↗
Editorial & leadership roles
journal and society appointments- Executive co-chair
Children's Brain Tumor Network
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →appointments.childrensnational.org ↗
Secondary affiliations
appointments beyond the home institution- Associate Professor of Pediatrics
George Washington University School of Medicine and Health Sciences
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →research.childrensnational.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Andrew Dauber, MD
Children's National
Roger Packer, MD
Children's National
Gil Wernovsky, MD
Children's National
Abdullah Feroze, MD
Children's National
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”